There were 853 USI procedures performed in the study period. 777 invitations were sent, once duplicates and deceased participants were excluded. Of the 404 (52%) participants who returned completed questionnaires, only 395 were included in the final analysis: 9 transobturator tape (TOT) responders were excluded as their numbers were too small for statistical analysis. Four groups were established for analysis: 226 retropubic mid-urethral tape tapes (TVT), 84 colposuspension, 51 Urethral bulking and 34 autologous fascial slings (AFS). The median follow-up was 5.9 years (range 1 to 10.1 years, SD +/- 2.5 years).
In terms of cure i.e. no SUI on ICIQ-FLUTS question 11a, TVT was significantly superior to colposuspension and urethral bulking (p<0.001). There was no difference between TVT and AFS in efficacy, with 63.8% TVT and 62.1% AFS reporting no SUI (p = 0.999). In terms of success on the ICIQ-S question 1, the TVT group were most satisfied with the outcome of their surgery. Satisfaction: 79.7% TVT, 69.1% colposuspension, 56% urethral bulking and 74.19% AFS. This did not reach statistical significance [except for TVT versus urethral bulking (p<0.001)]. On the patient global impression, ICIQ-S question 2, the urethral bulking group were least satisfied with the outcomes of their procedure: 75.9% TVT, 69.1% colposuspension, 45.8% urethral bulking and 87.1% AFS. Statistical significance was not reached [except for TVT and AFS versus urethral bulking (p<0.001)] (Table 1).
In terms of complications, the AFS group had the lowest reported rate of complications, question 12 ICIQ-S: 65.7% TVT, 67.1% colposuspension, 71.74% Urethral bulking and 22.6% AFS (p<0.001). Pain (question 11a ICIQ-S) was the most reported complication in all the groups, and there was no statistical difference between the groups although the AFS had the least pain. In terms of vaginal pain (question 2a ICIQ-VS), the TVT group scored the highest in reporting no vaginal pain, though this was not statistically significant between the groups: (p=0.553). This response was mirrored in the bladder pain question 4a ICIQ-FLUTS, where the TVT group once again scored highest in reporting no bladder pain: (p=0.35) (Table 2). In terms of sexual activity question 10 on ICIQ-VS, 7% of the TVT group reported not having a sex life because of their vaginal symptoms. This was statistically significant across the groups: 6.9% TVT, 17.9% colposuspension, 12.8% urethral bulking and 16.7% AFS (p=0.041). Urinary urgency was the most reported storage symptom in all the groups: 55.6% TVT, 60.2% colposuspension, 86.3% urethral bulking and 56.3% AFS (p < 0.001). Intermittent stream question 8a ICIQ-FLUTS was the most reported symptom of voiding dysfunction for all the groups. There was no difference between the groups: 37.7% TVT, 36.3% colposuspension, 38.8% Urethral bulking and 50% AFS (p=0.591).
TVT sub-analysis: When asked if they would recommend the surgery to friends or family question 5 ICIQ-S, 152/226 answered yes, 38/226 answered no and 36/226 were undecided. Qualitative assessment of the comments on complications provided by 32 of the TVT participants to ICIQ-S question 12 revealed three themes: 1) voiding dysfunction (12/32),2) recurrent urinary tract infections (9/32), and 3) tape erosion or pain requiring further surgery (6/32).
Overall, when all patients reported outcome measures (PROMs) were evaluated, the TVT procedure was reported to be the best procedure in terms of satisfaction and complication, with a total score of 0.682. This was closely followed by the AFS procedure at 0.678, then colposuspension 0.575, and finally urethral bulking 0.441.